Replies to post #13660 on Generex Biotechnology Corp. (fka GNBTQ)

[NYD]

The PR clearly states the following, "Generex has surpassed the final threshold and has completed its GMP manufacturing of its vaccine for human clinical trials, which is a key necessary component to be included in the company’s IND submission". No doubt, that is huge progress!
Regardless of what happened in the distant past, it appears GNBT is slowly but surely progressing toward something "big time" for it's shareholders. GLTA!